tb presentation lab diagosis sept 2013

107
MYCOBACTERIUM : DIAGNOSIS AND LABORATORY TEST 9/4/2013 1 Dr. Azura Hussin Pathology Department HRPZ II

Upload: unittbjknphg

Post on 16-Jul-2015

487 views

Category:

Healthcare


3 download

TRANSCRIPT

Page 1: Tb presentation lab diagosis  sept  2013

MYCOBACTERIUM : DIAGNOSIS AND LABORATORY TEST

9/4/2013

1

Dr. Azura HussinPathology Department

HRPZ II

Page 2: Tb presentation lab diagosis  sept  2013

Contents

9/4/2013

2

Introduction General characteristics of tubercle bacilli Lab diagnosis of tuberculosis - current technologies - newer technologies - problems in lab diagnosis - quality control Summary

Page 3: Tb presentation lab diagosis  sept  2013

Introduction

9/4/2013

3

Tuberculosis appears to be a disease as old as human history

Tuberculosis is a social disease with medical implications and it is a major public health problem

It remains the leading cause of death by infectious disease.

Tubercle bacillus discovered - more than a hundred years ago

First discovered in 1882 by Robert Koch - "Koch's bacillus

Page 4: Tb presentation lab diagosis  sept  2013

Introduction

12/09/14

4

According to the WHO, there are approximately 20 million active cases in the world today, and they infect 50-100 million people largely children annually.

The mortality is approximately 3 million annually (at least 80% from developing countries)

Malaysia, the number of cases detected per year has not declined substantially either.

Since 1989, 11,500 to 12,000 cases per year were detected

In 1995, 11,778 cases detected of which 6,500 cases are sputum positive and therefore are infectious.

Page 5: Tb presentation lab diagosis  sept  2013

9/4/2013

5

Why so high? HIV/AIDS Emergence of drug resistance TB Migration ? Early diagnosis of tuberculosis initiating optimal treatment - enable a cure curb the transmission of infection and

disease to others in the community.

Page 6: Tb presentation lab diagosis  sept  2013

9/4/2013

6

Page 7: Tb presentation lab diagosis  sept  2013

9/4/2013

7

Page 8: Tb presentation lab diagosis  sept  2013

DIAGNOSIS

Clinical :

- Symptoms (prolonged cough, fever, night sweats, LOA / W) and

- Signs (can be subtle as in minimal cases or obvious such as

consolidation, fibrosis or stony dullness due to pleural effusion)

Radiological and/ or

Bacteriological evidence

The tuberculin or Mantoux test

12/09/14

8

Page 9: Tb presentation lab diagosis  sept  2013

9/4/2013

9

TB is diagnosed by finding Myco ba c te rium tube rc ulo s is bacteria in a clinical specimen taken from the patient.

Other investigations may strongly suggest tuberculosis as the diagnosis, they cannot confirm it.

A definitive diagnosis of tuberculosis can only be made by culturing Myco ba c te rium tube rculo s is organisms from a specimen taken from the patient (most often sputum, but may also include pus, CSF, biopsied tissue, etc.).

A diagnosis made other than by culture may only be classified as "probable" or "presumed".

Page 10: Tb presentation lab diagosis  sept  2013

Transmission

9/4/201310

Page 11: Tb presentation lab diagosis  sept  2013

Kingdom BacteriaPhylum ActinobacteriaClass ActinobacteriaSubclass ActinobacteridaeOrder ActinomycetalesSuborder CorynebacterineaeFamily MycobacteriaceaeGenus Mycobacterium

unique genus

Species M. tuberculosisM. bovisM. africanumM. microti"M. canettii”M. capraeM. pinnipedii

Lineage of the agents of Mycobacterium

9/4/2013

11

Page 12: Tb presentation lab diagosis  sept  2013

Intro duc tio n - Members of Genus Myco ba c te rium

9/4/2013

12

Page 13: Tb presentation lab diagosis  sept  2013

Mycobacterium

9/4/2013

13

Mycobacterium Tuberculosis Complex (MTC)

species are closely related genetically differ in host, geographic range, certain

phenotypes and pathogenicity.

Among MTC – Mycobacterium Tuberculosis (MTB) is the most significant pathogen for human.

Page 14: Tb presentation lab diagosis  sept  2013

Caused by a bacteria - Mycobacterium tuberculosis

Rod shaped – slender or slightly curve

Size : 2-4 um x 0.2-0.5 um Non-motile Non-spore forming Obligate aerobe - lung Intracellular parasite

(monocytes/macrophages) Weak Gram positive

9/4/2013

14

Grows slowly (15-20 hrs)Optimum T : 37 C

Colonies take 4-6 weeks to become visible on LJ media.

can withstand weak disinfectants and can survive in a dry state for weeks

Page 15: Tb presentation lab diagosis  sept  2013

9/4/2013

15

Stains poorly by Gram Stain-”Ghosts”

Use heated Ziehl-Neelsen Carbol-fuchsin

Resists decolorizing by Acid-Alcohol → Acid-Fast

Page 16: Tb presentation lab diagosis  sept  2013

Colony Morphology Growth on LJ medium, colonies are rough, flat

with a raised centre, wrinkled

buff coloured, younger colonies are paler

Organisms tends to grow in parallel groups producing the colonial characteristics of serpentine coding

9/4/2013

16

Page 17: Tb presentation lab diagosis  sept  2013

# Colonies of Mycobacterium tuberculosis on Lowenstein Jensen medium. Colonies are small and buff coloured.

# In vitro-grown colonies often form distinctive serpentine cords. This observation was first made by Robert Koch who associated cord factor with virulent strains of the bacterium.

# It takes 4-6 weeks to get visual colonies 9/4/2013

17

Page 18: Tb presentation lab diagosis  sept  2013

MYCOLATE

Mycobacteria Gram-negative organisms

arabinogalactan

lipids lipid bilayer peptidoglycan

acyl lipid + LPS

lipid bilayer

Mycobacteria produce a thick mycolate-rich outer covering which functions as an exceptionally efficient barrier.

Cell wall

Unique cell wallMore than 60% lipid

Mycolic acids are hydrophobicCord Factor is toxic to mammalian cells

inhibits migration of Polymorphic Neutrophils9/4/2013

18

Page 19: Tb presentation lab diagosis  sept  2013

Mycobacterium Cell Wall

9/4/2013

19

High concentration of lipids cause:Impermeability to stains/dyesResistance to many antibioticsResistance to kill by acidic and

alkaline environments, even intracellularly

Resistance to osmotic lysis by Complement Fixation

Resistance to lethal oxidants

Page 20: Tb presentation lab diagosis  sept  2013

Makmal adalah komponen Makmal adalah komponen utama dalam -TB Controlutama dalam -TB Control

TIADA MAKMAL

TIADA DIAGNOSIS

TIADA PENGUBATAN

TIADA DOTS

TIADA TB CONTROL12/09/1420

Page 21: Tb presentation lab diagosis  sept  2013

Peranan MakmalPeranan Makmal

• Mengesan penyakit berjangkit

• Memantau kesan perawatan

• Memastikan kesembuhan pesakit

12/09/1421

Page 22: Tb presentation lab diagosis  sept  2013

Network Of TB Laboratory (Organization of TB Laboratory Services)

9/4/2013

22

District Hospitals

General Hospitals (State)

Institute of Respiratory Medicine

(MKAK Sungai Buloh)

Specimen collection centers/ some are examination centers

Examination centers (D/S)

Examination centers (D/S)

AFB Culture centers

TB Reference Laboratory

D/S, C/S, ID, BCG Viability Tests

Data compilation

Training / Set procedures

Health Center

Page 23: Tb presentation lab diagosis  sept  2013

Laboratory diagnosis

9/4/2013

23 There are numbers of diagnostic tests : simple AFB microscopy to complex molecular

techniques; The diagnostic modalities desirable features: sensitivity, specificity, reproducibility, cost effectiveness, safety, simplicity and easy application for wider use Quantitative - so that the infectiveness of the

individual cases can be measured

Page 24: Tb presentation lab diagosis  sept  2013

Specimen Collection - TB

Best specimen comes from the lung.

Saliva or nasal secretions are unsatisfactory.

Collect in open space- not toilets / dark unventilated rooms

Remove dentures and rinse mouth with water.

Inhale deeply 2–3 times, breathe out hard each time.

Cough deeply from the chest.

Place the open container close to the mouth to collect the specimen.

9/4/2013

24

What is a good sample and how to obtain it?

Page 25: Tb presentation lab diagosis  sept  2013

Samples for TB smear and culture Types of samples Sputum* CSF Gastric washing* Lymph nodes Tissues Stool urine

9/4/2013

25

Number of samplesAt least 2 or 3 fresh purulent samples from lower respiratory tract collected as spot – morning - spot Transportation

Ideally within one working day

* Induction sputum : smear negative / unable to produced sputum* Gastric lavage/Bronchoscopy : may considered in unsuitable sputum induction

Page 26: Tb presentation lab diagosis  sept  2013

Three samples required (Different day): Clinic patient:

Spot– morning – spot

Hospitalized patient: 3 morning specimens (better)

Yield increases rapidly after three specimens

9/4/2013

26Examples of containers

Page 27: Tb presentation lab diagosis  sept  2013

Reduction of number of smears for the diagnosis of pulmonary TB, 2007

Can be reduced from three to two, in places where a well-functioning external quality

assurance (EQA) system exists, where the workload is very high and human resources are limited.

WHO recommends the number of specimens to be examined for screening of TB cases

12/09/14

27

Page 28: Tb presentation lab diagosis  sept  2013

Tests offered - KKM

9/4/2013

28

Smears microscopic – ZN / IF Culture, sensitivity and identification PCR Line Probe Assay

Page 29: Tb presentation lab diagosis  sept  2013

Quality sample = Quality smearQuality smear = Quality lab result

9/4/2013

29

Page 30: Tb presentation lab diagosis  sept  2013

Specimen Quality

9/4/2013

30

Saliva/ Induced Sputum Blood Stained

Page 31: Tb presentation lab diagosis  sept  2013

Specimen Quality

9/4/2013

31

PurulentMucoid

Page 32: Tb presentation lab diagosis  sept  2013

Contents of a Sputum Specimen

Saliva (soluble in saline)

Mucous (from trachea & bronchus)

Sputum cup

Matters from pulmonary lesion(++++ bacil l i)Cheesy -yellowishComposition of a good

Sputum Specimen9/4/201332

Page 33: Tb presentation lab diagosis  sept  2013

Quality of Sputum % AFBSALIVA 4.9SALIVA + MUCUS 7.7MUCOPURULENT 19.2PURULENT 39.1

Distribution of AFB in the sputum specimen

9/4/2013

33

Page 34: Tb presentation lab diagosis  sept  2013

9/4/2013

34

SMEAR EXAMINATION

Z-N Stain

Fluorescent Stain

Light MicroscopeFluorescent Microscope

Specimen

Page 35: Tb presentation lab diagosis  sept  2013

Systematic Examination of Smears

9/4/2013

35

3 cm

2 cm

Page 36: Tb presentation lab diagosis  sept  2013

Uniform Smear Size

9/4/2013

36

Page 37: Tb presentation lab diagosis  sept  2013

Why We Do Sputum Smear Examination?

9/4/2013

37

Diagnosis -sign and symptoms - Monitoring

Positive sputum –smear = Infectious case

This in not a sensitive technique- but rapid and specific

Page 38: Tb presentation lab diagosis  sept  2013

OBSERVATION OF STAINED SMEAR-International Standard-

Examine the smear under x100 objective with the 10 eye piece lens

Read at least 300 visual fields to give a report a negative

9/4/2013

38

3 cm = 150 visual field

1

2

Page 39: Tb presentation lab diagosis  sept  2013

Microscopy

9/4/2013

39 the simplest and most rapid procedure currently available to detect AFB in clinical specimens by ZN staining method.

Page 40: Tb presentation lab diagosis  sept  2013

Microscopy

9/4/2013

40

Albert e t a l., 2002. Sensitivity: 61.3-63.4%

Highest – patients with cavitary disease Lowest – patients with weak cough / less

advanced disease Specificity: 97.3-97.4% AFB smear microscopy in symptomatic

patients has high specificity (98%) Concentration of sputum sample by

cytocentrifugation has been found to enhance the sensitivity to almost 100%.

Page 41: Tb presentation lab diagosis  sept  2013

Microscopy - limitation

9/4/2013

41

impossible to distinguish different mycobacterial species.

Sputum : 5 000 – 10,000 tubercle bacilli/ml – smear positive.

Smear negative on expectorated sputum→ Cannot rule-out TB (ie extra pulmonary TB)

Smear negative/ unable to produce sputum: Sputum induction Fiberoptic bronchoscopy Gastric washing

Page 42: Tb presentation lab diagosis  sept  2013

Good Quality Staining of AFB

9/4/2013

42

Page 43: Tb presentation lab diagosis  sept  2013

AFB in Single ArrangementAFB in Single Arrangement

9/4/201343

Page 44: Tb presentation lab diagosis  sept  2013

AFB - in Various Arrangements

9/4/2013

44

Page 45: Tb presentation lab diagosis  sept  2013

AFB in Clumps AFB in Clumps

9/4/201345

Page 46: Tb presentation lab diagosis  sept  2013

12/09/1446

AFB Stain-LED Fluorescence Microscope

Page 47: Tb presentation lab diagosis  sept  2013

LED Fluorescent microscope Advantages: Covers 15 times as many fields

compared to ZN Same area can be covered at

a shorter time Examination of slides for 1.41

min by FM equivalent to 2.48 min by ZN

Heating not required More sensitive - low bacillary

content Increase sensitivity of

conventional light microscope of about 10%

Less expensive ( maintenance, dark room)

Disadvantages:

Handling & maintenance of optical equipment require advanced skill Periodic replacement of

bulbs Continuous supply of power High cost of microscope and

maintenance Doubtful smears to be re

examined by ZN

12/09/14

47

Page 48: Tb presentation lab diagosis  sept  2013

METHOD ADVANTAGES DISADVANTAGESTechniques;Ziehl-NeelsenKinyounFlourochrome

Rapid Simple/Easy to read Specificity >98%. Minimal infrastructure

required to set up Indicator of infectious

case Treatment monitoring Retrospective checking – cultures growing are AFB

Tedious Less sensit ive (45-60%) (>100,000 bacil l i /ml) Trained &

experience microscopist

Presumptive diagnosis of mycobacterial dz Can’t

differentiate between species Can’t be use for

DST

Microscopy

9/4/201348

Page 49: Tb presentation lab diagosis  sept  2013

Culture

Advantages For susceptibility

testing Able to identify the

species of mycobacterium

9/4/2013

49

Disadvantages

Slow grower : delay in the lab diagnosis / treatment LaboriousExperience staffSpecial equipment Expensive

Page 50: Tb presentation lab diagosis  sept  2013

9/4/2013

50

Culture should be attempted1. For Surveillance of drug resistance as an

integral part of evaluation of control program2. Smear negative pulmonary & extra

pulmonary3. Childhood tuberculosis4. Follow up of Tuberculosis cases who fail to

respond to standard treatment5. Investigations of high risk individuals who

are symptomatic– HIV +ve cases– History of exposure to MDR cases– Laboratory workers

Page 51: Tb presentation lab diagosis  sept  2013

CULTUREMycobacterial culture can be

performed on:

Conventional : egg based solid medium Lowenstein-Jensen

medium Ogawa medium

Automated : Liquid based medium Kirschner™s or

Middlebrook 7H9 broth. Middle brook 7H12

9/4/2013

51

BACTEC MGIT 960 systemBacT/Alert 3DVersaTREK

Page 52: Tb presentation lab diagosis  sept  2013

Automated Mycobacteria Culture System

9/4/2013

52

1. Mycobacteria Growth detection.

2. Antimicrobial Susceptibility Testing (AST)

Page 53: Tb presentation lab diagosis  sept  2013

Myco ba c te rium tube rc ulo s is colonies on Middle Brook Agar.

9/4/2013

53

Page 54: Tb presentation lab diagosis  sept  2013

9/4/2013

54

Page 55: Tb presentation lab diagosis  sept  2013

BIOCHEMICAL IDENTIFICATION FOR MYCO BACTERIUM TUBERCULO SIS

9/4/2013

55

Biochemical Test Result

1 Niacin Test Positive

2 Catalase 68º C/pH 6.8 Negative

3 Nitrate Reduction Test Positive

Page 56: Tb presentation lab diagosis  sept  2013

9/4/2013

56

Nitrate Reduction Test

Catalase Test 68ºC/pH 7

Page 57: Tb presentation lab diagosis  sept  2013

New technologies - Molecular techniques

9/4/2013

57

Conventional PCR Real time PCR – direct detection from

samples # identification / sensitivity # detecting MDR / mutants gene associated with antibiotic resistant

Detection and identification of mycobacteria directly from clinical samples - an alternative for smear microscopy

Page 58: Tb presentation lab diagosis  sept  2013

9/4/2013

58

Line Probe Assay (LPA) - can be used to screen smear-positive sputum specimens for resistance to rifampicin and isoniazid in 1-2 days.

has the potential to substantially reduce the turnaround time of DST results.

training, supervision and adherence to stringent laboratory protocols to ensure high quality results during routine implementation

Page 59: Tb presentation lab diagosis  sept  2013

Tests take only hours to perform and may provide a rapid diagnosis, within 1-2 days of receipt of a sputum sample

Cannot replace culture and drug sensitivity tests Too expensive to be use routinely sensitivity : < 60% - > 95% <60% in smear negative (but positive for TB

culture) > 95% samples acid fast smear positive sputum

samples,

12/09/14

59

Page 60: Tb presentation lab diagosis  sept  2013

9/4/2013

60

Page 61: Tb presentation lab diagosis  sept  2013

9/4/2013

61

Page 62: Tb presentation lab diagosis  sept  2013

Lane 1: DNA Ladder MarkerLane 2: Sample 1Lane 3: Sample 2Lane 4: Sample 3Lane 5: Sample 4Lane 6 Sample 5Lane 7: PCR Pos ConLane 8: PCR Neg ConLane 9: Pos Ext ConLane 10: Neg Ext Con

9/4/2013

62

Page 63: Tb presentation lab diagosis  sept  2013

Serological diagnosis of Tuberculosis

9/4/2013

63

Should allow a rapid diagnosis, simple, cost effective

Most of the serological tests : low turn around time, high negative predictive value and are useful as

screening tests. Variable or low sensitivity : o 76% in smear positive cases, 59% in smear

negative cases, 64% in LN TB and 46% in pleural TB

expensive, require trained personnel and often have difficulty in distinguishing between M. tube rc ulo s is a nd NTM.

WHO (2011) : Patient safety- commercial serological assay should not be used to diagnose pulmonary or extra pulmonary TB

Page 64: Tb presentation lab diagosis  sept  2013

Some commercially available antibody tests for diagnosis of pulmonary TB

9/4/2013

64

Name of the assays Antigen used

MycoDot (Dot-blot) Lipo arabino mannan(LAM)

Detect-TB (ELISA) Recombinant protein PeptidePathozyme Myco(ELISA)

38 kDa (recombinant Ag) and LAM

Pathozyme TB(ELISA) 38 kDa (recombinant)Antigen A60 (ELISA) Antigen -60ICT diagnostics(membrane based)

38 kDa (recombinant)

Page 65: Tb presentation lab diagosis  sept  2013

Serological test - FOR LTBI

9/4/2013

65

Blood tests : T-SPOT.TB , QuantiFERON-TB Gold 393 consecutive with suspect TB had both tests –

blood and skin testPositive result: T-SPOT.TB of 38% vs QuantiFERON-TB Gold 26%

(p < 0.0001). Both blood tests showed similar overall agreement

with the skin test Blood tests were better than the skin test in

distinguishing BCG-vaccinated individuals from those with true positive results.

Indeterminate results 11% with QuantiFERON-TB Gold 3% with T-SPOT.TB (p < 0.0001).

Lancet 2006;367:1328-1334.

Page 66: Tb presentation lab diagosis  sept  2013

Detection of activated T-cells – producing gamma interferon

enable more people to be diagnosed and treated while their infection is still dormant / immune deficient

? thus a powerful new tool to help health authorities curb and control the TB epidemic

faster (results within 24 hours)

detecting antibodies induced by an infection

Painful, scarring False positive :- exposure / contact

with TB case- Post vaccination 3- 7 days to read the

induration 9/4/2013

66

TB Spot-TB

Skin Test

Page 67: Tb presentation lab diagosis  sept  2013

9/4/201367

High sensitivity (~90%) has been shown in culture confirmed TB patients

Specificity is also very high (>98%) even in BCG vaccinated individuals.

Page 68: Tb presentation lab diagosis  sept  2013

Additional procedure /diagnostic tests Extra pulmonary TB : histology or cytology TB lymphadenitis : FNA – cytology Pleural TB : thoracoscopy – histology/culture/

Adenosin Deaminase (ADA) TB meningitis : PCR / ADA

9/4/2013

68

Page 69: Tb presentation lab diagosis  sept  2013

Identification

9/4/2013

69

Only done in MKAK Sg. BulohConventionalNAAT ( Nucleic acid amplification

test)Hybridisation gene probe

Page 70: Tb presentation lab diagosis  sept  2013

QC

9/4/2013

70

Internal QC – staining materials

External QC Slides rechecking

Within same lab Within labs from same district / state

MKAK Sg. Buloh RCPA Australia

Page 71: Tb presentation lab diagosis  sept  2013

Problems in Lab. Dx

9/4/2013

71

The bacteria – slow growers Sample quality / criterion Wrong technique – STM not available Poor staining material Staff competency & attitude Equipment problem – microscope

Page 72: Tb presentation lab diagosis  sept  2013

Poor samples Improper

techniques Number of

organisms too small

Partially suppressed by antibiotics

Mycobacterial contamination of water or solutions

Transfer from +ve smears during staining or examination

Staining artefacts Insufficient

destaining of non AFB organisms

Other Acid fast organisms9/4/2013

72

False negative False positives

Page 73: Tb presentation lab diagosis  sept  2013

Delays of up to 2-3 weeks in starting anti-TB treatment is common

•Late intensive care admissions•In-hospital mortality•Nosocomial transmission•Inappropriate treatment

Impact of smear negative TB

9/4/2013

73

Page 74: Tb presentation lab diagosis  sept  2013

Tuberculosis Reference Laboratory

9/4/2013

74

1. National Public Health Laboratory, Ministry of Health Malaysia, Sungai Buloh, Selangor.

Page 75: Tb presentation lab diagosis  sept  2013

Role of TB Reference Laboratory

9/4/2013

75

To perform DST and Identification tests for AFB isolated from peripheral Laboratory

Standardization of Lab Techniques- To conduct training to technical staff (MLT) Compilation and monitoring data

Page 76: Tb presentation lab diagosis  sept  2013

Why Drug Susceptibility Tests (DST) ?

9/4/2013

76

DST done for 3 main purpose;I. As guidance in the choice of the first

course of chemotherapy.

II. To confirm emergence of drug resistance in a patient who failed to show bacteriological response to treatment and may guide the choice of further course.

III. May be employed to estimate prevalence of ;

- Primary Drug Resistance &

- Acquired Drug Resistance in the community

Page 77: Tb presentation lab diagosis  sept  2013

9/4/201377

Page 78: Tb presentation lab diagosis  sept  2013

Reporting

9/4/2013

78

TAT for slide smear shall be 24 hours from the time of specimen receipt (to be reviewed later)

TAT for identification : 3 days after specimen receipt at MKAK Sg Buloh

TAT for sensitivity : preliminary – 17 days final – 31 days

Page 79: Tb presentation lab diagosis  sept  2013

WHO Quantification scale Ziehl Neelsen

Number of AFB Number of fields* examined

What to report

No AFB in 300 fields 300 fields

No Acid Fast Bacilli seen

1–9 AFB in 100 fields 100 fields

Record exact figure (1 to 9 AFB per 100 fields)

10– 99 AFB in 100 fields 100 fields

1 +

1– 10 AFB in each field 50 fields

2 +

More than 10 AFB in each field 20 fields

3 +

9/4/2013

79

* Oil immersion fields

Page 80: Tb presentation lab diagosis  sept  2013

9/4/201380

Page 81: Tb presentation lab diagosis  sept  2013

9/4/201381

Page 82: Tb presentation lab diagosis  sept  2013

9/4/201382

Page 83: Tb presentation lab diagosis  sept  2013

9/4/201383

Page 84: Tb presentation lab diagosis  sept  2013

KELEMAHAN PEWARNAAN

9/4/2013

84

Page 85: Tb presentation lab diagosis  sept  2013

Penyelengaraan Mikroskop yang baik

12/09/14

85

Page 86: Tb presentation lab diagosis  sept  2013

Slide artefact - Excessive Heat Slide artefact - Excessive Heat Fixing of SmearFixing of Smear

9/4/201386

Page 87: Tb presentation lab diagosis  sept  2013

Slide artefact - Glass Slide Slide artefact - Glass Slide Scratch and AFBScratch and AFB

9/4/201387

Page 88: Tb presentation lab diagosis  sept  2013

Soot Deposit on Underside of Soot Deposit on Underside of SmearSmear

12/09/1488

Page 89: Tb presentation lab diagosis  sept  2013

What Are the Causes of Pale Staining AFB?

12/09/14

89

Page 90: Tb presentation lab diagosis  sept  2013

Pale Staining AFBPale Staining AFB

12/09/1490

Page 91: Tb presentation lab diagosis  sept  2013

Causes of Pale Staining AFB Concentration of CF <0.3%:

Staining time less than 5 minutes

Inadequate heating of carbol fuchsin on the slide

Excessive exposure time with an acid alcohol decoloriser may remove the carbol fuchsin from the AFB

12/09/14

91

Page 92: Tb presentation lab diagosis  sept  2013

Time Effect of Carbol Fuchsin on Intensity of AFB

2 min

12/09/14

92

Page 93: Tb presentation lab diagosis  sept  2013

3 min

12/09/1493

Page 94: Tb presentation lab diagosis  sept  2013

5 min

12/09/1494

Page 95: Tb presentation lab diagosis  sept  2013

Effect of Not Heating the Carbol Effect of Not Heating the Carbol Fuchsin to SteamingFuchsin to Steaming

12/09/1495

Page 96: Tb presentation lab diagosis  sept  2013

What Are the Causes of Excessive Counterstaining ?

Leaving counterstain on slide for longer than one minute

Methylene blue concentration > 0.3%

12/09/14

96

Page 97: Tb presentation lab diagosis  sept  2013

Good Quality CounterstainGood Quality Counterstain

12/09/1497

Page 98: Tb presentation lab diagosis  sept  2013

Excessive CounterstainExcessive Counterstain

12/09/1498

Page 99: Tb presentation lab diagosis  sept  2013

Effect of Excessive Counterstain-1Effect of Excessive Counterstain-1

c

Nuclei too dark

Background too strong

12/09/1499

Page 100: Tb presentation lab diagosis  sept  2013

Effect of Excessive Counterstain-2Effect of Excessive Counterstain-2

Background too strong

12/09/14100

Page 101: Tb presentation lab diagosis  sept  2013

Combination of Excessive Combination of Excessive Counterstain & Poorly Stained AFBCounterstain & Poorly Stained AFB

12/09/14101

Page 102: Tb presentation lab diagosis  sept  2013

What Are the Causes of Insufficient Decolorisation?

12/09/14

102

Page 103: Tb presentation lab diagosis  sept  2013

Assessment of Smear QualityAssessment of Smear Quality

Uneven smear preparation and insufficient decolorisation

12/09/14103

Page 104: Tb presentation lab diagosis  sept  2013

Insufficient Decolourisation Insufficient Decolourisation

12/09/14104

Page 105: Tb presentation lab diagosis  sept  2013

Importance of Correct Importance of Correct DecolourisationDecolourisation

Insufficient Correct

12/09/14105

Page 106: Tb presentation lab diagosis  sept  2013

Summary

9/4/2013

106

Tuberculosis still stands as the most important infectious disease in humans despite of the advances in treatment.

Early and accurate detection of active cases remains an important objective for improved implementation of chemotherapy and for reduction in the spread of the disease.

The identification of the mycobacteria will depends on the quality of sample and the lab techniques

Several limitations to the traditional techniques used.

New techniques / diagnostic tests : to improved the diagnosis and shortened the testing time in the laboratory.

Page 107: Tb presentation lab diagosis  sept  2013

9/4/2013107